why choose us

First received: July 19, 2026

Clinical Trial: ESCC Molecular Subtypes Based on Multidimensional Features of p53 and Their Clinical Significance

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: P53 Mutation in Esophageal Cancer

Study Type: OBSERVATIONAL


Official Title: ESCC Molecular Subtypes Based on Multidimensional Features of p53 and Their Clinical Significance

Brief Summary: Collect 300 esophageal cancer tissue specimens, including cancer tissue and serum, from a biological sample bank. Collect clinical information on esophageal cancer, including gender, age, time of diagnosis, time of death, treatment information, TNM staging, tumor size, location, etc. DNA sequencing was performed on 300 collected esophageal cancer samples, divided into mutant and wild-type types. Perform immunohistochemistry on tissue slices and observe the expression of P53 mutant protein. ELISA was used to study…

Read more